Contract Changes [4181BH, 2022-04-01]

40
4181BH
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB (C)
PHA
4ML VIAL
C
856.27
2022-04-01
2023-04-18
Delete from contract
2023-03-07